Loading...
MediPal Holdings Corporation
MAHLY•PNK
Healthcare
Medical - Distribution
$16.48
$0.00(0.00%)
MediPal Holdings Corporation (MAHLY) Financial Performance & Income Statement Overview
Review MediPal Holdings Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.16%
↑ 3.16%
Operating Income Growth
17.49%
↑ 17.49%
Net Income Growth
-2.88%
↓ 2.88%
Operating Cash Flow Growth
-2.08%
↓ 2.08%
Operating Margin
1.51%
↑ 1.51%
Gross Margin
6.97%
↑ 6.97%
Net Profit Margin
1.10%
↑ 1.10%
ROE
6.53%
↑ 6.53%
ROIC
6.82%
↑ 6.82%
MediPal Holdings Corporation (MAHLY) Income Statement & Financial Overview
Review MediPal Holdings Corporation's (MAHLY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $864.16B | $982.50B | $915.36B | $909.32B |
| Cost of Revenue | $806.02B | $914.72B | $851.51B | $846.72B |
| Gross Profit | $58.13B | $67.78B | $60.46B | $62.60B |
| Gross Profit Ratio | $0.07 | $0.07 | $0.07 | $0.07 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $47.89B | $46.19B | $46.58B | $45.96B |
| Operating Expenses | $47.89B | $49.57B | $49.96B | $49.32B |
| Total Costs & Expenses | $853.92B | $964.29B | $901.48B | $896.03B |
| Interest Income | $35.00M | $3.00M | $7.00M | $5.00M |
| Interest Expense | $2.00M | $2.00M | $2.00M | $1.00M |
| Depreciation & Amortization | $4.65B | $4.63B | $4.65B | $4.50B |
| EBITDA | $15.44B | $30.80B | $27.06B | $21.86B |
| EBITDA Ratio | $0.02 | $0.03 | $0.03 | $0.02 |
| Operating Income | $10.24B | $18.21B | $13.88B | $13.28B |
| Operating Income Ratio | $0.01 | $0.02 | $0.02 | $0.01 |
| Other Income/Expenses (Net) | $553.00M | $7.96B | $8.53B | $4.08B |
| Income Before Tax | $10.79B | $26.17B | $22.41B | $17.36B |
| Income Before Tax Ratio | $0.01 | $0.03 | $0.02 | $0.02 |
| Income Tax Expense | $4.49B | $8.51B | $6.84B | $5.36B |
| Net Income | $4.04B | $14.51B | $12.72B | $9.008B |
| Net Income Ratio | $0.005 | $0.01 | $0.01 | $0.010 |
| EPS | $19.43 | $69.78 | $61.00 | $42.95 |
| Diluted EPS | $19.43 | $69.78 | $61.00 | $42.95 |
| Weighted Avg Shares Outstanding | $207.96M | $207.95M | $208.52M | $209.72M |
| Weighted Avg Shares Outstanding (Diluted) | $207.96M | $207.95M | $208.52M | $209.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan